Glenview Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tenet Healthcare
THC
|
+$75.6M |
| 2 |
Aptiv
APTV
|
+$75.3M |
| 3 |
Flex
FLEX
|
+$55.7M |
| 4 |
Amazon
AMZN
|
+$55.3M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$51.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
+$99.8M |
| 2 |
Centene
CNC
|
+$90.8M |
| 3 |
Encompass Health
EHC
|
+$68.9M |
| 4 |
Coca-Cola Europacific Partners
CCEP
|
+$57.8M |
| 5 |
Cigna
CI
|
+$38.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.12% |
| 2 | Technology | 21.31% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 9.45% |
| 5 | Materials | 7.97% |
Similar funds
Glenview Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Glenview Capital Management held 65 positions worth $4B, up 0.05% from $4B the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Glenview Capital Management deployed $136M of net new capital in Q3 2022, opening 10 new positions and adding to 18 existing holdings. Its largest new stake was Alibaba: 419,428 shares worth $33.5M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 43% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Encompass Health, an estimated $68.9M trimmed.
- Glenview Capital Management's largest Q3 2022 buy was Alibaba: 419,428 shares worth $33.5M.
- Glenview Capital Management added most to Tenet Healthcare in Q3 2022, an estimated $75.6M increase.
- Glenview Capital Management's biggest Q3 2022 reduction was Encompass Health, cutting an estimated $68.9M.
- Glenview Capital Management fully exited Change Healthcare Inc. Common Stock in Q3 2022, selling an estimated $99.8M.
- Glenview Capital Management's ten largest holdings make up 61% of its $4B portfolio in Q3 2022.
- Glenview Capital Management opened 10 new positions and closed 11 in Q3 2022.
- Glenview Capital Management's portfolio value rose 0.05% quarter-over-quarter to $4B.
Based on Glenview Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.